Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HIRU | US
-0.00
-16.67%
Healthcare
Biotechnology
30/06/2024
09/03/2026
0.00
0.00
0.00
0.00
Hiru Corporation through its subsidiary produces Chinese herbs for the naturopathic industry in China. It manufactures herbal supplements containing ginseng. The company sells and distributes pharmaceuticals health and beauty products dietary and herbal supplements and other healthcare products. It manufactures approximately 120 extracts used in traditional Chinese medicine. Hiru Corporation sells its products through regional distributors as well as directly to the hospitals clinics and pharmacies in China. Hiru Corporation was formerly known as Phoenix Restaurant Group Inc. and changed its name to Hiru Corporation in November 2008. The company is based in Phoenix Arizona.
View LessLow Market Beta (-0.4 to 0.8)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
276.7%1 month
216.8%3 months
190.9%6 months
222.8%-
-
-
2.63
0.71
-0.07
0.01
-
5.92M
3.78M
3.78M
-
8.99
-
-
19.68
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.01
Range1M
0.01
Range3M
0.01
Rel. volume
1.60
Price X volume
198.54K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Iterum Therapeutics plc | ITRM | Biotechnology | 0.1788 | 4.06M | 8.04% | n/a | -198.11% |
| Brainstorm Cell Therapeutics Inc | BCLI | Biotechnology | 0.7297 | 3.88M | 2.77% | n/a | -27.28% |
| XTL Biopharmaceuticals Ltd | XTLB | Biotechnology | 0.702 | 3.83M | -3.58% | n/a | 0.00% |
| Cyclerion Therapeutics Inc | CYCN | Biotechnology | 1.49 | 3.75M | 5.67% | n/a | 0.00% |
| 60 Degrees Pharmaceuticals Inc. Common Stock | SXTP | Biotechnology | 1.93 | 3.59M | -5.85% | n/a | 5.19% |
| Enzon Pharmaceuticals Inc | ENZN | Biotechnology | 0.05 | 3.57M | -16.67% | 12.00 | 0.00% |
| Xenetic Biosciences Inc | XBIO | Biotechnology | 2.31 | 3.56M | 0.87% | n/a | 0.00% |
| AquaBounty Technologies Inc | AQB | Biotechnology | 0.9 | 3.48M | -2.91% | n/a | 10.41% |
| Akari Therapeutics Plc | AKTX | Biotechnology | 0.2512 | 3.05M | 0.00% | n/a | -27.01% |
| Matinas BioPharma Holdings Inc | MTNB | Biotechnology | 0.6037 | 3.03M | 0.45% | n/a | 16.97% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.47 | 3.75M | -0.67% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.39 | 3.71M | -1.76% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.46 | 1.36M | 2.93% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.008 | 737.72K | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.07 | 0.53 | Cheaper |
| Ent. to Revenue | 0.01 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 190.88 | 72.80 | Riskier |
| Debt to Equity | 2.63 | -1.23 | Expensive |
| Debt to Assets | 0.71 | 0.25 | Expensive |
| Market Cap | 3.78M | 3.66B | Emerging |